A Randomized, Double-Blind, Placebo-Controlled Trial of Once Daily Atomoxetine Hydrochloride to Evaluate Efficacy in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children Ages 6-12 with an Assessment of Evening Behavior
Not available
Attention Deficit Hyperactivity Disorder
Phase 3
A link to and a NCT ID number are not available for this study because the study was conducted before regulatory requirements to register studies.
November 2015